The viewpoint of the committee and the algorithm developed are, in many ways, very similar to the article previously published by this author on this topic. [3] The current commentary will review the ...

Researchers suggest bisphosphonate could potentially reduce the risk of colorectal cancer, but more randomized trials should be carried out to confirm their results, according to an Internal Medicine ...

Conclusion: Bisphosphonates provide a supportive, albeit expensive and non–life-prolonging, benefit to many patients with bone metastases. Current research is focusing on bisphosphonates as adjuvant ...

Prescription claims data were searched to identify the first claim for raloxifene or a bisphosphonate between January 2003 and December 2004 for patients. In the commercial/Medicare data 102,750 ...